Mitrade Insights is dedicated to providing investors with rich, timely and most valuable financial information to help investors grasp the market situation and find timely trading opportunities.

2021

Best News & Analysis Provider

FxDailyInfo

2022

Best Forex Educational Resources Global

International Business Magazine

Insights

News

10X Genomics Inc Stock (TXG) Moved Up by 7.42% on Sep 24: What Signal Does It Send?

Source Tradingkey

10X Genomics Inc (TXG) moved up by 7.42%. The Healthcare Services & Equipment sector is up by 0.04%. The company outperformed the industry. Top 3 stocks by turnover in the sector: Thermo Fisher Scientific Inc (TMO) up 1.05%; Unitedhealth Group Inc (UNH) down 0.02%; Danaher Corp (DHR) up 1.01%.

SummaryOverview

What is driving 10X Genomics Inc (TXG)’s stock price up today?

The upward movement in 10x Genomics stock reflects strong momentum and renewed buying interest following recent intraday volatility. Technical indicators, including positive moving average convergence divergence shifts and bullish trend signals, have catalyzed buying among momentum-driven market participants. The stock's capacity to rebound sharply demonstrates sustained institutional interest as traders capitalize on favorable technical setups and ongoing short-covering activity.

Fundamental catalysts are playing a central role in driving investor optimism surrounding the company's long-term commercial trajectory. Markets have responded favorably to enthusiasm and order momentum for the Atera spatial biology platform, which delivers whole-transcriptome spatial analysis at single-cell resolution. Sentiment has been further bolstered by strategic collaborations, including the integration of Lunit's AI pathology capabilities into the Xenium and Atera workflows, reinforcing the firm's position in oncology research and biomarker discovery.

Intellectual property litigation victories against industry peers have provided additional clarity and market confidence by protecting key technology assets. Although macro pressures on academic and biopharma research budgets continue to present potential sector-wide headwinds, the convergence of product innovation, strategic AI integrations, and expanding spatial biology adoption continues to draw capital toward the company as a key growth player in life science tools.

Technical Analysis of 10X Genomics Inc (TXG)

Technically, 10X Genomics Inc (TXG) shows a MACD (12,26,9) value of 1.227, indicating a buy signal. The RSI at 70.496 suggests buy condition and the Williams %R at 6.201 suggests overbought condition. Please monitor closely.

Fundamental Analysis of 10X Genomics Inc (TXG)

10X Genomics Inc (TXG) is in the Healthcare Services & Equipment industry. Its latest annual revenue is $642.82M, ranking 78 in the industry. The net profit is $-43.54M, ranking 181 in the industry. Company Profile

FundamentalAnalysis

Over the past month, multiple analysts have rated the company as Buy, with an average price target of $57.07, a high of $90.00, and a low of $40.00.

More details about 10X Genomics Inc (TXG)

Company Specific Risks:

Extreme Valuation Disconnect and Price Target Downside: Following a sharp multi-fold rally to a 52-week high of $82.68, TXG suffered a steep intraday pullback as market commentary highlighted an extreme price-to-sales multiple of over 16x, leaving the stock heavily overvalued relative to the consensus analyst price target of $44.00 and modeled fair value estimates of $49.54.
Persistent Operational Losses and Top-Line Contraction: Recent financial reporting underscores structural profitability challenges, evidenced by a Q2 2026 operating loss of $19.6 million and net loss of $17.9 million alongside a year-over-year total revenue decline to $151.0 million, as lower instrument pricing continues to pressure gross margins.
Insider Dispositions and Heavy Distribution Pressure: Regulatory Form 4 and Rule 144 filings disclose sustained insider selling, including multi-million-dollar sales by Chief Financial Officer Adam Taich and over $9.3 million in aggregate insider stock liquidations in recent months, dampening institutional sentiment during intraday rallies.
High Short Interest and Technical Overbought Reversal: Short interest has climbed to 13.61% of the total float with 5.51 days to cover, combining with extreme overbought momentum indicators (RSI reaching 78) to trigger technical sell signals and amplify downside intraday price swings.

Source

Disclaimer: For information purposes only. Past performance is not indicative of future results.

Recommended Articles

Dollar holds above 100 near a 3-month high — three Fed speakers and a $69 billion auction land tonight The dollar index closed at 100.43 on Monday, its highest close since late July, after a weekly gain of about 1% — the best in more than three months — and is holding above the 100.00 handle in Asia. Three Fed officials speak tonight alongside a $69 billion two-year note auction, the first leg of $183 billion of Treasury supply this week.

Author Suzie

Sep 22, Tue

The dollar index closed at 100.43 on Monday, its highest close since late July, after a weekly gain of about 1% — the best in more than three months — and is holding above the 100.00 handle in Asia. Three Fed officials speak tonight alongside a $69 billion two-year note auction, the first leg of $183 billion of Treasury supply this week.

October hike odds climb toward 60% as Goldman and BofA both flip — what Warsh's "dose of accommodation" really changed Rate futures now price roughly 55% to 62% for a 25bp hike at the October 27-28 FOMC, up from about 30% before Chair Warsh's post-meeting framing that the Fed is merely "removing some accommodation." Goldman Sachs has added an October hike to its forecast and Bank of America now sees moves in both October and December. Here is the repricing, the language behind it, and the two data points that decide it.

Author Irene Q.

Sep 23, Wed

Rate futures now price roughly 55% to 62% for a 25bp hike at the October 27-28 FOMC, up from about 30% before Chair Warsh's post-meeting framing that the Fed is merely "removing some accommodation." Goldman Sachs has added an October hike to its forecast and Bank of America now sees moves in both October and December. Here is the repricing, the language behind it, and the two data points that decide it.

Memory chips surge, Nasdaq notches a second straight record close — why the Dow fell 185 points anyway Micron gained 5%, SanDisk 6.8%, Seagate 4% and Western Digital 3% as the memory complex led the Nasdaq Composite to a second consecutive record close of 27,244.28. But the Dow fell 185 points as JPMorgan, Wells Fargo and Schwab slid more than 3% each — a split tape that says more about positioning than about the economy.

Author Irene Q.

Sep 23, Wed

Micron gained 5%, SanDisk 6.8%, Seagate 4% and Western Digital 3% as the memory complex led the Nasdaq Composite to a second consecutive record close of 27,244.28. But the Dow fell 185 points as JPMorgan, Wells Fargo and Schwab slid more than 3% each — a split tape that says more about positioning than about the economy.

Gold Price Forecast: XAU/USD drifts toward $4.300 with bears gaining traction Gold (XAU/USD) retraces Tuesday’s gains on Wednesday and drifts lower, approaching the $4,300 area as the US Dollar Index (DXY) rallies further amid high US Treasury yields.

Author FXStreet

Sep 23, Wed

Gold (XAU/USD) retraces Tuesday’s gains on Wednesday and drifts lower, approaching the $4,300 area as the US Dollar Index (DXY) rallies further amid high US Treasury yields.

US input costs rose at the fastest pace in four years — the September flash PMI beat is an inflation story, not a growth story US September flash PMIs came in far above expectations, with the composite at 58.4, a five-year high. But the detail that moved markets was input cost inflation at its fastest since October 2022, driven by fuel, transport and supply shortages. Brent is back above $100 and the 10-year Treasury yield has hit its highest since 2007.

Author Suzie

Yesterday 06: 46

US September flash PMIs came in far above expectations, with the composite at 58.4, a five-year high. But the detail that moved markets was input cost inflation at its fastest since October 2022, driven by fuel, transport and supply shortages. Brent is back above $100 and the 10-year Treasury yield has hit its highest since 2007.

Popular Symbols